Notice: This company has been marked as potentially delisted and may not be actively trading. Sigilon Therapeutics (SGTX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Lilly & Co Eli's Net WorthMay 1, 2024 | benzinga.comMCRB Seres Therapeutics, Inc.April 14, 2024 | seekingalpha.comBeam Therapeutics Inc.October 22, 2023 | wsj.comWhy These 3 Large Caps Are Bucking the August Slump (SGTX)The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023.August 22, 2023 | marketbeat.comEli Lilly Concludes Acquisition Of Sigilon TherapeuticsAugust 14, 2023 | markets.businessinsider.comLilly Completes Acquisition of Sigilon TherapeuticsAugust 14, 2023 | finance.yahoo.comTrading was temporarily halted for "SGTX" at 07:08 PM with a stated reason of "News pending."August 11, 2023 | marketbeat.comSGTX - Sigilon Therapeutics, Inc.August 1, 2023 | finance.yahoo.comInside Eli Lilly's Strategic Investment In Sigilon: An Opportunity OverlookedJuly 31, 2023 | msn.comSIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon ...July 21, 2023 | businesswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNMJuly 18, 2023 | markets.businessinsider.comCanaccord Genuity Maintains Sigilon Therapeutics (SGTX) Buy RecommendationJuly 6, 2023 | msn.comSigilon Therapeutics (SGTX) Price Target Decreased by 6.27% to 48.28July 6, 2023 | msn.com5 big deal reports: Overstock snags Bed Bath & Beyond IP; Visa pays $1B for PismoJuly 3, 2023 | msn.comSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Sigilon Therapeutics, Inc. BuyoutJune 29, 2023 | benzinga.comModerna Billionaire Set to Score 3,000% Gain on Tiny BiotechJune 29, 2023 | finance.yahoo.comEli Lilly and Company: Lilly to Acquire Sigilon TherapeuticsJune 29, 2023 | finanznachrichten.deHealth Care Company Eli Lilly Announces Acquisition of Sigilon TherapeuticsJune 29, 2023 | msn.comSigilon stock up 500% on Lilly acquisition newsJune 29, 2023 | bizjournals.comSigilon Therapeutics Shares Are Shooting Higher Today - What's Going OnJune 29, 2023 | finance.yahoo.comTrading was temporarily halted for "SGTX" at 09:06 AM with a stated reason of "LULD pause."June 29, 2023 | marketbeat.comSigilon stock skyrockets 650% on buyout deal with Eli LillyJune 29, 2023 | msn.comEli Lilly To Acquire Sigilon TherapeuticsJune 29, 2023 | markets.businessinsider.comWhy Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?June 29, 2023 | msn.comSGTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sigilon Therapeutics, Inc. Is Fair to ShareholdersJune 29, 2023 | technews.tmcnet.comLilly to Acquire Sigilon TherapeuticsJune 29, 2023 | finance.yahoo.comEli Lilly to buy Sigilon Therapeutics to expand diabetes treatmentsJune 29, 2023 | finance.yahoo.comMorgan Stanley Sticks to Their Hold Rating for Sigilon Therapeutics (SGTX)May 26, 2023 | markets.businessinsider.comMorgan Stanley Maintains Sigilon Therapeutics (SGTX) Equal-Weight RecommendationMay 25, 2023 | msn.comSigilon Therapeutics's Return On Capital Employed OverviewMay 24, 2023 | msn.comTrading was temporarily halted for "SGTX" at 11:05 AM with a stated reason of "LULD pause."May 23, 2023 | marketbeat.comSigilon Therapeutics, Inc.: Sigilon Announces Reverse Stock Split of Common StockMay 22, 2023 | finanznachrichten.deSigilon Therapeutics Announces One-for-13 Reverse Stock Split - Quick FactsMay 22, 2023 | markets.businessinsider.comSigilon Therapeutics to effect 13-for-1 reverse stock splitMay 22, 2023 | msn.comSigilon Announces Reverse Stock Split of Common StockMay 22, 2023 | finance.yahoo.comSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports First Quarter 2023 Financial Results and Business HighlightsMay 9, 2023 | finanznachrichten.deSigilon Therapeutics GAAP EPS of -$0.23 in-line, revenue of $4.86M beats by $1.76MMay 9, 2023 | msn.comSigilon Therapeutics to Present at the Needham Virtual Healthcare ConferenceApril 18, 2023 | finance.yahoo.comRevenues Working Against Sigilon Therapeutics, Inc.'s (NASDAQ:SGTX) Share Price Following 34% DiveApril 17, 2023 | finance.yahoo.comSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsMarch 15, 2023 | finanznachrichten.deSigilon Therapeutics GAAP EPS of -$0.21 beats by $0.17, revenue of $2.64M misses by $0.03MMarch 14, 2023 | msn.comSigilon Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Business HighlightsMarch 14, 2023 | finance.yahoo.comTrading was temporarily halted for "SGTX" at 10:03 AM with a stated reason of "LULD pause."March 14, 2023 | marketbeat.comShort Volatility Alert: Sigilon TherapeuticsFebruary 28, 2023 | benzinga.comWhy Starbox Group Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving PremarketJanuary 19, 2023 | msn.comSigilon Therapeutics Third Quarter 2022 Earnings: Beats ExpectationsNovember 12, 2022 | finance.yahoo.comSigilon Therapeutics, Inc.: Sigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business HighlightsNovember 10, 2022 | finanznachrichten.deSigilon Therapeutics Reports Third Quarter 2022 Financial Results and Business HighlightsNovember 10, 2022 | finance.yahoo.comSigilon Therapeutics, Inc. (SGTX) Reports Q3 Loss, Tops Revenue EstimatesNovember 10, 2022 | finance.yahoo.comDelix Therapeutics Expands World-Class Team with First Head of R&DSeptember 24, 2022 | finance.yahoo.com Get Sigilon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Nvidia warning urgent (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. SGTX Media Mentions By Week SGTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGTX News Sentiment▼0.000.44▲Average Medical News Sentiment SGTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGTX Articles This Week▼01▲SGTX Articles Average Week Get Sigilon Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SGTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ZNTL News Today SCPH News Today ETON News Today PROC News Today ATAI News Today RZLT News Today FULC News Today PYXS News Today NKTX News Today BIVI News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sigilon Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sigilon Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
